NOVT

Novanta

NOVT

Attention (50-day avg)0%

Attention rank (50-day avg)#1,048

Bullish sentiment (50-day avg)100%

Price to earnings ratio89.9

Market capitalization5.4B

Earnings per share1.58

Dividend yield (TTM)—

Revenue (annual)980.6M

Net income (annual)53.8M

Social

What share of all stock conversation is about NOVT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% -0.01	0% +0	0% +0

May 28

Novanta Inc. ($NOVT) has exposure to both linear and rotary drivers/actuators/encoders, used in surgical robotics.
The company partnered with Nvidia's Halos AI lab, providing precision, reliability, and safety for humanoid robotics.
Novanta's servos and drives were selected for Nvidia's Halos AI Systems Inspection Lab, simplifying certification and integration with Nvidia platforms.

Generated by AI

Sentiment

Of the messages about NOVT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% 0	99.52% +25.61
Bearish	—	0% 0	0% 0	0.48% -25.61

Feb 13

Novanta's chart looks excellent, with a strong potential for returns, making it a great medium-term investment.
The company is a quality fundamental play with a solid investment case, offering a huge upside with minimal downside risk.
Institutions are heavily buying Novanta, and the stock has a strong growth in earnings per share over the past 5 years, making it a promising long-term hold.

Generated by AI

Topics

Of the messages about NOVT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	96.3%	99.89%	89.44%
Macro	0%	3.7%	0.11%	1.07%
Technical Analysis	0%	0%	0%	3.65%
Earnings	0%	0%	0%	4.02%
Analysts	0%	0%	0%	1.82%
Controversies	0%	0%	0%	0%

Earnings· Mar 1

Novanta Inc. (NOVT) reported Q4 2022 earnings with non-GAAP EPS of $0.75, beating estimates by $0.03, and revenue of $218.4M, beating estimates by $2.83M.
The company guided Q1 2023 EPS below estimate and revenue below estimate, and FY23 EPS below the high end of the estimate range.
Novanta Inc. (NOVT) updated FY2023 guidance to $3.00-$3.20 EPS and revenue guidance to $890.00 million-$915.00 million.

Announcements· Mar 1

Novanta Inc. (NOVT) reported financial results for the fourth quarter and full year 2022, with revenue increasing to $218.4M and $860.9M, respectively.
The company's adjusted operating income and adjusted EBITDA also saw significant growth, reaching $147.5M and $184.1M for the full year 2022.
Novanta's diluted EPS for the full year 2022 was $2.06, a 46.48% increase from the previous year, with a non-GAAP adjusted diluted EPS of $3.07.

Generated by AI

Community

Of the messages about NOVT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	1.71%	4.81%
Newcomers	100%	100%	98.29%	95.19%

Regulars· Mar 1

Novanta Inc. ($NOVT) reported Q4 2022 earnings with non-GAAP EPS of $0.75 beating estimates by $0.03, and revenue of $218.4M beating by $2.83M.
The company announced financial results for the fourth quarter and full year 2022, with non-GAAP EPS of $0.75 and GAAP EPS of $0.42.
Novanta Inc. (NOVT) filed form 8-K on March 01, reporting results of operations and financial condition, with financial statements and exhibits included.

Newcomers· May 13

Novanta's Q1 bookings jumped 37% YoY, with a book-to-bill ratio of 1.10, exceeding expectations.
The company raised its annual guidance after the strong quarter, driven by increased demand in robotics and physical AI.
Analyst Blair maintains an Outperform rating on Novanta, citing opportunities in EUV lithography, humanoids, and warehouse applications.

Generated by AI

Recent commentary on Novanta (NOVT) has focused on its revenue growth profile and projected demand pickup, with solid gross margins drawing new attention to how the stock’s recent returns compare with those fundamentals. Short term trading pressure has been clear, with the share price down 9.2% over the past week and 14.3% over 90 days. Yet Novanta’s year to date share price return of 19.8% and 1 year total shareholder return of 16.1% point to momentum that has cooled rather than...

10d agoYahoo Finance

Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?

In recent commentary, Novanta (NASDAQ:NOVT) has been highlighted for its multi-year annual revenue growth of 10.7% and a gross margin of 44.4%, reflecting perceived market share gains and strong product positioning. This attention centers on Novanta’s combination of demand acceleration expectations and high-margin products, which analysts view as evidence of superior competitive capabilities. Next, we will examine how this focus on Novanta’s revenue momentum and margins may influence the...

10d agoYahoo Finance

Novanta director Thomas Secor sells $97,858 in stock

14d agoInvesting.com

$1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today

22d agobenzinga.com

Novanta’s (NOVT) Second Quarter Shows Profits Outrunning Sales

On August 5, Novanta Inc. (NASDAQ:NOVT) reported second quarter results showing something rarer than strong revenue growth: profit growth that beat it by a wide margin. Revenue rose 10.3% year over year to $265.8 million, but net income nearly tripled and cash from operations quadrupled. That kind of gap between the top and bottom line […]

25d agoYahoo Finance

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

BOSTON, August 28, 2026--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY.

1mo agoYahoo Finance

Also Discussed

Investors talking about NOVT also mention

#	Name	Attention
1	Cognex CorpCGNX	0%0
2	IPG Photonics CorporationIPGP	0%0
3	Regal Rexnord CorporationRRX	0%-0.01
4	Everspin Technologies, Inc.MRAM	0%0
5	Helios Technologies, Inc.HLIO	0%0
6	Allient Inc.ALNT	0%0
7	Moog Inc.MOG.A	0%new
8	Vishay Precision Group Inc.VPG	0%0
9	Materion CorpMTRN	0%new
10	Aeva Technologies Inc.AEVA	0.01%+0.01

Novanta Inc.

Technology
Scientific & Technical Instruments

Novanta Inc. is a global technology company that provides core solutions for medical and advanced industrial equipment manufacturers. Novanta designs and manufactures precision photonics, vision, and motion control components and subsystems used in applications such as laser processing, robotics, automation, metrology, and scientific instrumentation. The company also supplies medical technologies for surgical imaging, visualization, identification, and other clinical workflows, supporting original equipment manufacturers across healthcare and life science markets. Novanta operates through its Automation Enabling Technologies and Medical Solutions segments, serving customers in North America, Europe, and Asia Pacific. Headquartered in Bedford, Massachusetts, Novanta focuses on mission-critical technologies that help its customers build highly specialized systems requiring precision, reliability, and performance.

Website

Location

125 Middlesex Turnpike

Bedford, MA, 01730

United States

Social

What share of all stock conversation is about NOVT?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% -0.01	0% +0	0% +0

May 28

Novanta Inc. ($NOVT) has exposure to both linear and rotary drivers/actuators/encoders, used in surgical robotics.
The company partnered with Nvidia's Halos AI lab, providing precision, reliability, and safety for humanoid robotics.
Novanta's servos and drives were selected for Nvidia's Halos AI Systems Inspection Lab, simplifying certification and integration with Nvidia platforms.

Generated by AI

Sentiment

Of the messages about NOVT that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% 0	100% 0	99.52% +25.61
Bearish	—	0% 0	0% 0	0.48% -25.61

Feb 13

Novanta's chart looks excellent, with a strong potential for returns, making it a great medium-term investment.
The company is a quality fundamental play with a solid investment case, offering a huge upside with minimal downside risk.
Institutions are heavily buying Novanta, and the stock has a strong growth in earnings per share over the past 5 years, making it a promising long-term hold.

Generated by AI

Topics

Of the messages about NOVT that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	100%	96.3%	99.89%	89.44%
Macro	0%	3.7%	0.11%	1.07%
Technical Analysis	0%	0%	0%	3.65%
Earnings	0%	0%	0%	4.02%
Analysts	0%	0%	0%	1.82%
Controversies	0%	0%	0%	0%

Earnings· Mar 1

Novanta Inc. (NOVT) reported Q4 2022 earnings with non-GAAP EPS of $0.75, beating estimates by $0.03, and revenue of $218.4M, beating estimates by $2.83M.
The company guided Q1 2023 EPS below estimate and revenue below estimate, and FY23 EPS below the high end of the estimate range.
Novanta Inc. (NOVT) updated FY2023 guidance to $3.00-$3.20 EPS and revenue guidance to $890.00 million-$915.00 million.

Announcements· Mar 1

Novanta Inc. (NOVT) reported financial results for the fourth quarter and full year 2022, with revenue increasing to $218.4M and $860.9M, respectively.
The company's adjusted operating income and adjusted EBITDA also saw significant growth, reaching $147.5M and $184.1M for the full year 2022.
Novanta's diluted EPS for the full year 2022 was $2.06, a 46.48% increase from the previous year, with a non-GAAP adjusted diluted EPS of $3.07.

Generated by AI

Community

Of the messages about NOVT, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	1.71%	4.81%
Newcomers	100%	100%	98.29%	95.19%

Regulars· Mar 1

Novanta Inc. ($NOVT) reported Q4 2022 earnings with non-GAAP EPS of $0.75 beating estimates by $0.03, and revenue of $218.4M beating by $2.83M.
The company announced financial results for the fourth quarter and full year 2022, with non-GAAP EPS of $0.75 and GAAP EPS of $0.42.
Novanta Inc. (NOVT) filed form 8-K on March 01, reporting results of operations and financial condition, with financial statements and exhibits included.

Newcomers· May 13

Novanta's Q1 bookings jumped 37% YoY, with a book-to-bill ratio of 1.10, exceeding expectations.
The company raised its annual guidance after the strong quarter, driven by increased demand in robotics and physical AI.
Analyst Blair maintains an Outperform rating on Novanta, citing opportunities in EUV lithography, humanoids, and warehouse applications.

Generated by AI

Novanta

Social

May 28

Sentiment

Feb 13

Topics

Earnings· Mar 1

Announcements· Mar 1

Community

Regulars· Mar 1

Newcomers· May 13

News

Is Novanta (NOVT) A Bargain Following Strong Growth And Demand Outlook?

Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?

Novanta director Thomas Secor sells $97,858 in stock

$1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today

Novanta’s (NOVT) Second Quarter Shows Profits Outrunning Sales

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

Also Discussed

Novanta Inc.

Company Information

Location

Social

May 28

Sentiment

Feb 13

Topics

Earnings· Mar 1

Announcements· Mar 1

Community

Regulars· Mar 1

Newcomers· May 13

News

Is Novanta (NOVT) A Bargain Following Strong Growth And Demand Outlook?

Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?

Novanta director Thomas Secor sells $97,858 in stock

$1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today

Novanta’s (NOVT) Second Quarter Shows Profits Outrunning Sales

Novanta to Present at Baird Global Healthcare Conference on Tuesday, September 15, 2026

Also Discussed